Versant Venture Capital VI, L.P.

Track record

How each disclosed position did against the S&P ~6 months later

No positions we can measure against the market yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$0.0000 bought · −$73.17M sold

All filings on record

Every Form 4 transaction we track for this filer

All10Buys0Sells10

Stock	Transaction	Date	~6mo vs S&P
LENZLENZ Therapeutics, Inc.	Sell $5.8K · 123 sh	2025-09-30	—
LENZLENZ Therapeutics, Inc.	Sell $8.3K · 177 sh	2025-09-30	—
LENZLENZ Therapeutics, Inc.	Sell $2.67M · 57,502 sh	2025-09-30	—
LENZLENZ Therapeutics, Inc.	Sell $3.85M · 83,066 sh	2025-09-30	—
LENZLENZ Therapeutics, Inc.	Sell $1.56M · 34,405 sh	2025-09-30	—
LENZLENZ Therapeutics, Inc.	Sell $2.25M · 49,701 sh	2025-09-30	—
LVTXLAVA Therapeutics NV	Sell $746.8K · 532,870 sh	2025-09-19	—
LVTXLAVA Therapeutics NV	Sell $3.32M · 2,370,533 sh	2025-09-19	—
LENZLENZ Therapeutics, Inc.	Sell $5.7K · 132 sh	2025-09-18	—
LENZLENZ Therapeutics, Inc.	Sell $11.6K · 268 sh	2025-09-18	—

LENZSell

2025-09-30 · LENZ Therapeutics, Inc.

$5.8K

—

LENZSell

2025-09-30 · LENZ Therapeutics, Inc.

$8.3K

—

LENZSell

2025-09-30 · LENZ Therapeutics, Inc.

$2.67M

—

LENZSell

2025-09-30 · LENZ Therapeutics, Inc.

$3.85M

—

LENZSell

2025-09-30 · LENZ Therapeutics, Inc.

$1.56M

—

LENZSell

2025-09-30 · LENZ Therapeutics, Inc.

$2.25M

—

LVTXSell

2025-09-19 · LAVA Therapeutics NV

$746.8K

—

LVTXSell

2025-09-19 · LAVA Therapeutics NV

$3.32M

—

LENZSell

2025-09-18 · LENZ Therapeutics, Inc.

$5.7K

—

LENZSell

2025-09-18 · LENZ Therapeutics, Inc.

$11.6K

—

Newest 10 of 42 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

OS

Olsson Shawn

LENZ · last 2025-11-17

DK

Dhingra Kapil

LVTX · last 2025-11-13

HS

Hurly Stephen A

LVTX · last 2025-11-13

PF

Powell Fred M

LVTX · last 2025-11-13

WK

Wilson Karen J

LVTX · last 2025-11-13

CD

Chevallard Daniel R.

LENZ · last 2025-11-07

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.